Baldwin Insurance Group, Inc. (BWIN) · Oct 27, 2026 · Earnings

Baldwin Insurance earnings miss as Medicare disruption offsets CAC gains

Miss — Adjusted EPS $0.42 vs ~$0.43 consensus; revenue $480.3M vs ~$492.7M

Baldwin Insurance’s Q3 earnings miss consensus on revenue and adjusted EPS, as Medicare disruption offsets CAC integration gains and margin progress.

Baldwin is a partnership-led insurance brokerage using acquisitions such as CAC to expand specialty and middle-market capabilities, while trying to turn integration savings and cross-selling into durable organic growth. This preliminary update says the acquisition engine is working operationally, but the core growth picture is softer than the headline revenue growth suggests.

The quarter missed a published consensus on both key earnings measures. Revenue was $480.3 million versus roughly $492.7 million expected, while adjusted diluted EPS was $0.42 versus about $0.43 expected. The filing reports Q3 revenue growth of 31%, adjusted EBITDA growth of 47%, and adjusted EPS growth of 35% year over year, but the absolute figures still came in below the market’s near-term bar. (Financial Highlights)

MetricQ3 2026Comparison
Revenue$480.3M (Financial Highlights)+31% YoY; ~$492.7M consensus
Organic revenue growth6% (Financial Highlights)6.1% reported; 8.3% normalized including January partnerships (Performance Headwinds Explained)
Adjusted EBITDA$106.9M (Adjusted EBITDA Bridge)+47% YoY
Adjusted diluted EPS$0.42 (Financial Highlights)+35% YoY; ~$0.43 consensus
Adjusted free cash flow$56M (Financial Highlights)+33% YoY
Net leverage4.4x (Key Debt Metrics)4.1x in Q3 2025

The underlying growth engine is better than the reported organic number, but not cleanly strong. CAC, Obie and Capstone collectively grew year-over-year revenue by 16% in Q3, and management says those January 2026 partnerships reduced reported organic growth by 170 basis points because they will not enter the comparable base until 2027. Excluding the Medicare drag, reported organic growth would have been 6.6%; including the partnership effect, management calculates normalized growth at 8.3%. (Performance Headwinds Explained) That makes the miss more about timing and mix than a collapse in demand, but the company still has to prove that normalized growth converts into recurring organic growth once acquisition comparisons roll through.

CAC integration is ahead of plan and is the clearest positive offset. Baldwin has actioned more than $35 million of its $43 million three-year expense-synergy target and realized more than $5 million of its $17 million revenue-synergy target, with an $11 million-plus cross-sell pipeline underway. The filing also says integration progress is running ahead of plan. 〔0〕 This supports the strategic rationale for CAC, but the gains are not yet enough to overcome the quarter’s softer top-line delivery.

Medicare is the main business-specific setback. The roughly $55 million Medicare operation faced major plan changes and provider exits; record new enrollments were up 50%, but elevated renewal churn offset that momentum. Management expects stabilization during the rest of 2026, but that remains an outlook claim rather than demonstrated recovery. The issue matters because it cuts organic growth in a business where new enrollment momentum is not translating cleanly into retained revenue.

Margins improved, but leverage remains a constraint on the acquisition model. Q3 adjusted EBITDA margin rose to 22% from 20% a year earlier, and adjusted free cash flow increased to $56 million. However, net leverage was 4.4x, above the company’s stated goal of getting below 4.0x, with $2.276 billion of net debt and a 6.5% weighted-average rate. (Key Debt Metrics) The business is producing more cash and executing synergies, but debt reduction remains slower than the strategic plan requires.

Bottom line: This is a modest earnings miss, not a breakdown in the CAC thesis. Integration and margins are tracking well, but Medicare disruption and still-elevated leverage leave Baldwin’s growth-and-deleveraging story behind the market’s near-term expectations.

What to watch next

Q3 2026 Form 10-Q filing

Original filing on SEC EDGAR

More Baldwin Insurance Group, Inc. news

Baldwin Insurance earnings miss as Medicare disruption offsets CAC gains | BWIN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.